Greenwich Lifesciences Stock Market Capitalization
| GLSI Stock | USD 10.31 0.42 3.91% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Greenwich Lifesciences' long-term financial health and intrinsic value.
| Last Reported | Projected for Next Year | ||
| Market Cap | 146.2 M | 276.3 M |
Greenwich | Market Capitalization | Build AI portfolio with Greenwich Stock |
Greenwich Lifesciences Company Market Capitalization Analysis
Greenwich Lifesciences' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Greenwich Lifesciences Market Capitalization | 148.66 M |
Most of Greenwich Lifesciences' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Greenwich Lifesciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Greenwich Market Capitalization Driver Correlations
Understanding the fundamental principles of building solid financial models for Greenwich Lifesciences is extremely important. It helps to project a fair market value of Greenwich Stock properly, considering its historical fundamentals such as Market Capitalization. Since Greenwich Lifesciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Greenwich Lifesciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Greenwich Lifesciences' interrelated accounts and indicators.
Click cells to compare fundamentals
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of Greenwich Lifesciences is about 148.66 M. This is 98.85% lower than that of the Biotechnology sector and 96.86% lower than that of the Health Care industry. The market capitalization for all United States stocks is 99.22% higher than that of the company.
Greenwich Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Greenwich Lifesciences' direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Greenwich Lifesciences could also be used in its relative valuation, which is a method of valuing Greenwich Lifesciences by comparing valuation metrics of similar companies.Greenwich Lifesciences is currently under evaluation in market capitalization category among its peers.
Greenwich Lifesciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Greenwich Lifesciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Greenwich Lifesciences' managers, analysts, and investors.Environmental | Governance | Social |
Greenwich Fundamentals
| Return On Equity | -5.43 | ||||
| Return On Asset | -2.54 | ||||
| Current Valuation | 144.85 M | ||||
| Shares Outstanding | 13.85 M | ||||
| Shares Owned By Insiders | 50.59 % | ||||
| Shares Owned By Institutions | 9.51 % | ||||
| Number Of Shares Shorted | 1.61 M | ||||
| Price To Book | 68.04 X | ||||
| EBITDA | (15.79 M) | ||||
| Net Income | (15.79 M) | ||||
| Cash And Equivalents | 15.64 M | ||||
| Cash Per Share | 1.22 X | ||||
| Total Debt | 1.56 M | ||||
| Current Ratio | 65.74 X | ||||
| Book Value Per Share | 0.16 X | ||||
| Cash Flow From Operations | (7.27 M) | ||||
| Short Ratio | 20.24 X | ||||
| Earnings Per Share | (1.46) X | ||||
| Target Price | 45.0 | ||||
| Beta | 2.92 | ||||
| Market Capitalization | 148.66 M | ||||
| Total Asset | 4.09 M | ||||
| Retained Earnings | (66.15 M) | ||||
| Working Capital | 2.53 M | ||||
| Net Asset | 4.09 M |
About Greenwich Lifesciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Greenwich Lifesciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Greenwich Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Greenwich Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Greenwich Lifesciences Piotroski F Score and Greenwich Lifesciences Altman Z Score analysis. For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Greenwich Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.